SK129198A3 - Purification of pharmaceutical-grade plasmid dna - Google Patents

Purification of pharmaceutical-grade plasmid dna Download PDF

Info

Publication number: SK129198A3
Authority: SK; Slovakia
Prior art keywords: dna; plasmid; sequence; buffer; column
Prior art date: 1996-03-21

Application number

SK1291-98A

Other languages

English (en)

Slovak (sk)

Inventor

Pierre Wils

Monique Ollivier

Original Assignee

Rhone Poulenc Rorer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-21

Filing date

1997-03-17

Publication date

1999-03-12

1997-03-17 Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa

1999-03-12 Publication of SK129198A3 publication Critical patent/SK129198A3/sk

Links

239000013612 plasmid Substances 0.000 title claims abstract description 113
238000000746 purification Methods 0.000 title claims description 26
108020004414 DNA Proteins 0.000 claims abstract description 159
238000000034 method Methods 0.000 claims abstract description 90
229910052588 hydroxylapatite Inorganic materials 0.000 claims abstract description 36
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims abstract description 36
102000053602 DNA Human genes 0.000 claims abstract description 27
239000000919 ceramic Substances 0.000 claims abstract description 22
230000008569 process Effects 0.000 claims abstract description 19
238000004440 column chromatography Methods 0.000 claims abstract description 16
239000013611 chromosomal DNA Substances 0.000 claims abstract description 13
108091034117 Oligonucleotide Proteins 0.000 claims description 67
238000011026 diafiltration Methods 0.000 claims description 22
238000004587 chromatography analysis Methods 0.000 claims description 21
238000002360 preparation method Methods 0.000 claims description 13
238000001042 affinity chromatography Methods 0.000 claims description 12
239000002158 endotoxin Substances 0.000 claims description 12
238000009396 hybridization Methods 0.000 claims description 11
230000009089 cytolysis Effects 0.000 claims description 10
238000004255 ion exchange chromatography Methods 0.000 claims description 10
239000000126 substance Substances 0.000 claims description 8
108091028043 Nucleic acid sequence Proteins 0.000 claims description 6
108020004511 Recombinant DNA Proteins 0.000 claims description 4
239000008194 pharmaceutical composition Substances 0.000 claims description 2
239000000203 mixture Substances 0.000 abstract description 11
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 63
239000000872 buffer Substances 0.000 description 52
239000000499 gel Substances 0.000 description 27
108091032973 (ribonucleotides)n+m Proteins 0.000 description 26
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 26
108090000623 proteins and genes Proteins 0.000 description 26
239000000243 solution Substances 0.000 description 25
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 19
239000002773 nucleotide Substances 0.000 description 19
125000003729 nucleotide group Chemical group 0.000 description 19
239000008363 phosphate buffer Substances 0.000 description 18
239000000523 sample Substances 0.000 description 17
210000004027 cell Anatomy 0.000 description 16
238000004128 high performance liquid chromatography Methods 0.000 description 16
239000002299 complementary DNA Substances 0.000 description 15
102000039446 nucleic acids Human genes 0.000 description 15
108020004707 nucleic acids Proteins 0.000 description 15
150000007523 nucleic acids Chemical class 0.000 description 15
239000000047 product Substances 0.000 description 15
102000004169 proteins and genes Human genes 0.000 description 15
239000012528 membrane Substances 0.000 description 14
241000588724 Escherichia coli Species 0.000 description 13
239000012634 fragment Substances 0.000 description 13
239000011780 sodium chloride Substances 0.000 description 13
239000000463 material Substances 0.000 description 12
239000011148 porous material Substances 0.000 description 11
239000006166 lysate Substances 0.000 description 10
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 10
108060001084 Luciferase Proteins 0.000 description 8
230000000295 complement effect Effects 0.000 description 8
230000010076 replication Effects 0.000 description 8
239000005089 Luciferase Substances 0.000 description 7
239000006228 supernatant Substances 0.000 description 7
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
239000011543 agarose gel Substances 0.000 description 6
238000005119 centrifugation Methods 0.000 description 6
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 6
229960005542 ethidium bromide Drugs 0.000 description 6
230000004048 modification Effects 0.000 description 6
238000012986 modification Methods 0.000 description 6
239000002244 precipitate Substances 0.000 description 6
210000001236 prokaryotic cell Anatomy 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 5
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Natural products O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 5
239000002253 acid Substances 0.000 description 5
238000000855 fermentation Methods 0.000 description 5
230000004151 fermentation Effects 0.000 description 5
230000003993 interaction Effects 0.000 description 5
235000011056 potassium acetate Nutrition 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
238000000870 ultraviolet spectroscopy Methods 0.000 description 5
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
102000004190 Enzymes Human genes 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 4
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
239000012148 binding buffer Substances 0.000 description 4
238000010276 construction Methods 0.000 description 4
239000003599 detergent Substances 0.000 description 4
229940088598 enzyme Drugs 0.000 description 4
238000005342 ion exchange Methods 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
239000003550 marker Substances 0.000 description 4
239000003960 organic solvent Substances 0.000 description 4
239000012521 purified sample Substances 0.000 description 4
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 3
101710163270 Nuclease Proteins 0.000 description 3
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 3
102000005891 Pancreatic ribonuclease Human genes 0.000 description 3
150000001412 amines Chemical group 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
230000008901 benefit Effects 0.000 description 3
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 3
239000013592 cell lysate Substances 0.000 description 3
238000009390 chemical decontamination Methods 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
239000012141 concentrate Substances 0.000 description 3
238000011109 contamination Methods 0.000 description 3
238000010828 elution Methods 0.000 description 3
210000003527 eukaryotic cell Anatomy 0.000 description 3
230000014509 gene expression Effects 0.000 description 3
235000010335 lysozyme Nutrition 0.000 description 3
230000014759 maintenance of location Effects 0.000 description 3
230000002572 peristaltic effect Effects 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
230000035939 shock Effects 0.000 description 3
125000006850 spacer group Chemical group 0.000 description 3
229940104230 thymidine Drugs 0.000 description 3
231100000331 toxic Toxicity 0.000 description 3
230000002588 toxic effect Effects 0.000 description 3
238000005406 washing Methods 0.000 description 3
239000003643 water by type Substances 0.000 description 3
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
229920002271 DEAE-Sepharose Polymers 0.000 description 2
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
108090000204 Dipeptidase 1 Proteins 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
102000016943 Muramidase Human genes 0.000 description 2
108010014251 Muramidase Proteins 0.000 description 2
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
108091093037 Peptide nucleic acid Proteins 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
229920002684 Sepharose Polymers 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
108020004682 Single-Stranded DNA Proteins 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
238000000246 agarose gel electrophoresis Methods 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
230000006037 cell lysis Effects 0.000 description 2
238000002659 cell therapy Methods 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000000356 contaminant Substances 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
238000001514 detection method Methods 0.000 description 2
238000009792 diffusion process Methods 0.000 description 2
SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
239000003814 drug Substances 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
238000000605 extraction Methods 0.000 description 2
230000001605 fetal effect Effects 0.000 description 2
239000000835 fiber Substances 0.000 description 2
238000001914 filtration Methods 0.000 description 2
239000012467 final product Substances 0.000 description 2
101150045500 galK gene Proteins 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
239000008103 glucose Substances 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
239000012535 impurity Substances 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
229930027917 kanamycin Natural products 0.000 description 2
229960000318 kanamycin Drugs 0.000 description 2
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
229930182823 kanamycin A Natural products 0.000 description 2
239000004325 lysozyme Substances 0.000 description 2
229960000274 lysozyme Drugs 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 2
239000002245 particle Substances 0.000 description 2
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
239000000376 reactant Substances 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000001488 sodium phosphate Substances 0.000 description 2
229910000162 sodium phosphate Inorganic materials 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
125000003396 thiol group Chemical group [H]S* 0.000 description 2
230000009466 transformation Effects 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
238000005199 ultracentrifugation Methods 0.000 description 2
239000013598 vector Substances 0.000 description 2
VJUBYQUPDRGGMP-UHFFFAOYSA-N (morpholin-4-ylamino)phosphonous acid Chemical compound OP(O)NN1CCOCC1 VJUBYQUPDRGGMP-UHFFFAOYSA-N 0.000 description 1
CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
244000058084 Aegle marmelos Species 0.000 description 1
235000003930 Aegle marmelos Nutrition 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
239000005695 Ammonium acetate Substances 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
238000009631 Broth culture Methods 0.000 description 1
101100297345 Caenorhabditis elegans pgl-2 gene Proteins 0.000 description 1
108091036055 CccDNA Proteins 0.000 description 1
108020004638 Circular DNA Proteins 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
238000007399 DNA isolation Methods 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
102000002322 Egg Proteins Human genes 0.000 description 1
108010000912 Egg Proteins Proteins 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
239000004593 Epoxy Substances 0.000 description 1
241000233866 Fungi Species 0.000 description 1
241000282412 Homo Species 0.000 description 1
241000701024 Human betaherpesvirus 5 Species 0.000 description 1
241000235649 Kluyveromyces Species 0.000 description 1
239000006137 Luria-Bertani broth Substances 0.000 description 1
PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
241000772600 Norion Species 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241000254064 Photinus pyralis Species 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
239000004695 Polyether sulfone Substances 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
102000018120 Recombinases Human genes 0.000 description 1
108010091086 Recombinases Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
-1 Superose Polymers 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
108700019146 Transgenes Proteins 0.000 description 1
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Natural products O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 1
241000700605 Viruses Species 0.000 description 1
CIHUOJZDKZENCP-UHFFFAOYSA-N acetonitrile;triethylazanium;acetate Chemical compound CC#N.CC(O)=O.CCN(CC)CC CIHUOJZDKZENCP-UHFFFAOYSA-N 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
238000003916 acid precipitation Methods 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
150000001299 aldehydes Chemical group 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
235000019257 ammonium acetate Nutrition 0.000 description 1
229940043376 ammonium acetate Drugs 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000011324 bead Substances 0.000 description 1
235000015278 beef Nutrition 0.000 description 1
239000012620 biological material Substances 0.000 description 1
125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
239000000969 carrier Substances 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000013043 chemical agent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
238000010367 cloning Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
WRTKMPONLHLBBL-KVQBGUIXSA-N dXTP Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(NC(=O)NC2=O)=C2N=C1 WRTKMPONLHLBBL-KVQBGUIXSA-N 0.000 description 1
238000004200 deflagration Methods 0.000 description 1
230000000593 degrading effect Effects 0.000 description 1
101150106284 deoR gene Proteins 0.000 description 1
238000010511 deprotection reaction Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
235000014103 egg white Nutrition 0.000 description 1
210000000969 egg white Anatomy 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
238000011013 endotoxin removal Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000000945 filler Substances 0.000 description 1
238000011049 filling Methods 0.000 description 1
238000009472 formulation Methods 0.000 description 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000004927 fusion Effects 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000011194 good manufacturing practice Methods 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000009776 industrial production Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000009434 installation Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000004190 ion pair chromatography Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
239000002502 liposome Substances 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000002609 medium Substances 0.000 description 1
238000005374 membrane filtration Methods 0.000 description 1
230000011987 methylation Effects 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical group CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
239000003068 molecular probe Substances 0.000 description 1
231100000219 mutagenic Toxicity 0.000 description 1
230000003505 mutagenic effect Effects 0.000 description 1
239000002105 nanoparticle Substances 0.000 description 1
238000001821 nucleic acid purification Methods 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
238000012856 packing Methods 0.000 description 1
230000010412 perfusion Effects 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
150000004713 phosphodiesters Chemical class 0.000 description 1
150000008039 phosphoramides Chemical class 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920006393 polyether sulfone Polymers 0.000 description 1
230000006920 protein precipitation Effects 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
239000012429 reaction media Substances 0.000 description 1
230000009467 reduction Effects 0.000 description 1
239000013074 reference sample Substances 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
YZHUMGUJCQRKBT-UHFFFAOYSA-M sodium chlorate Chemical compound [Na+].[O-]Cl(=O)=O YZHUMGUJCQRKBT-UHFFFAOYSA-M 0.000 description 1
238000003860 storage Methods 0.000 description 1
231100000378 teratogenic Toxicity 0.000 description 1
230000003390 teratogenic effect Effects 0.000 description 1
238000012360 testing method Methods 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
150000003568 thioethers Chemical class 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
239000010891 toxic waste Substances 0.000 description 1
238000001890 transfection Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
AVBGNFCMKJOFIN-UHFFFAOYSA-N triethylammonium acetate Chemical compound CC(O)=O.CCN(CC)CC AVBGNFCMKJOFIN-UHFFFAOYSA-N 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
231100000925 very toxic Toxicity 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
238000005303 weighing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Analytical Chemistry (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
Crystallography & Structural Chemistry (AREA)
Immunology (AREA)
Plant Pathology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Saccharide Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SK1291-98A 1996-03-21 1997-03-17 Purification of pharmaceutical-grade plasmid dna SK129198A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9603519A FR2746412B1 (fr)	1996-03-21	1996-03-21	Purification d'adn plasmidique de qualite pharmaceutique
PCT/FR1997/000472 WO1997035002A1 (fr)	1996-03-21	1997-03-17	Purification d'adn plasmidique de qualite pharmaceutique

Publications (1)

Publication Number	Publication Date
SK129198A3 true SK129198A3 (en)	1999-03-12

Family

ID=9490391

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK1291-98A SK129198A3 (en)	1996-03-21	1997-03-17	Purification of pharmaceutical-grade plasmid dna

Country Status (15)

Country	Link
US (1)	US6730781B1 (fr)
EP (1)	EP0902835A1 (fr)
JP (1)	JP2000506736A (fr)
KR (1)	KR100502116B1 (fr)
AU (1)	AU730755B2 (fr)
BR (1)	BR9708227A (fr)
CA (1)	CA2249465A1 (fr)
CZ (1)	CZ295587B6 (fr)
FR (1)	FR2746412B1 (fr)
HU (1)	HU225426B1 (fr)
IL (1)	IL126268A0 (fr)
NO (1)	NO984342D0 (fr)
SK (1)	SK129198A3 (fr)
WO (1)	WO1997035002A1 (fr)
ZA (1)	ZA972462B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7026468B2 (en)	1996-07-19	2006-04-11	Valentis, Inc.	Process and equipment for plasmid purification
US7807822B2 (en)	1996-08-01	2010-10-05	Robert Bridenbaugh	Methods for purifying nucleic acids
US6214586B1 (en) *	1997-12-08	2001-04-10	Genzyme Corporation	Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA
SK287662B6 (sk) *	2000-05-26	2011-05-06	Centelion	Spôsob purifikácie dvojvláknovej DNA použitím imobilizovaného oligonukleotidu
FR2822476B1 (fr) *	2001-03-23	2004-04-02	Aventis Pharma Sa	Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice
MXPA03008642A (es) *	2001-03-23	2004-06-30	Gencell Sa	Metodos de purificacion y de deteccion de secuencias objetivo de adn de doble hebra mediante interaccion de triple helice.
EP1554398A4 (fr)	2002-09-13	2005-12-14	Valentis Inc	Appareil et procede de purification a l'echelle de la chimie preparatoire d'acides nucleiques
US7238522B2 (en)	2003-05-30	2007-07-03	Advisys, Inc.	Devices and methods for biomaterial production
CN1882682B (zh) *	2003-09-17	2010-06-16	森特利昂公司	药物级别质粒dna的制备方法
EP2246413A3 (fr) *	2004-04-19	2011-10-26	Centelion	Procédé de préparation d'ADN plasmide de qualité pharmaceutique
CA2559368A1 (fr) *	2004-04-19	2005-10-27	Centelion	Procede destine a purifier de l'adn plasmidique
MX2007001847A (es)	2004-08-16	2007-04-13	Nature Technology Corp	Cepas mejoradas de e.coli para la produccion de adn de plasmido.
EP1817423B1 (fr)	2004-11-30	2015-01-07	Merial Ltd.	Melangeurs pour chimiolyse de cellules
US20120258502A1 (en) *	2011-04-08	2012-10-11	Vinod Pandiripally	Method of producing recombinant plasmid dna using substantially solid growth medium
US20120283503A1 (en) *	2011-04-29	2012-11-08	The Johns Hopkins University	Nanoparticle loaded stem cells and their use in mri guided hyperthermia
CN116790578B (zh) *	2023-08-22	2023-12-12	赛奥斯博生物科技(北京)有限公司	一种基于碱裂解法快速纯化质粒的生产工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2691586B2 (ja) *	1987-10-22	1997-12-17	旭光学工業株式会社	多孔質セラミックス及びその製法
JPH01135792A (ja) *	1987-11-20	1989-05-29	Mitsui Toatsu Chem Inc	核酸の分離・精製方法
CA2006008C (fr) *	1988-12-20	2000-02-15	Donald J. Kessler	Methode pour obtenir des oligonucleotides synthetiques qui se lient specifiquement a des sites cibles sur des molecules d'adn double brin, en formant un triplex colineaire; methode d'utilisation de ces oligonucleotides synthetiques
WO1994016075A2 (fr) *	1993-01-13	1994-07-21	Genetics Institute, Inc.	Procede de production de m-csf 223
US5503816A (en) *	1993-09-27	1996-04-02	Becton Dickinson And Company	Silicate compounds for DNA purification
DE59505786D1 (de) *	1994-02-07	1999-06-02	Qiagen Gmbh	Verfahren zur abreicherung oder entfernung von endotoxinen
US5576196A (en) *	1995-01-13	1996-11-19	Vical Incorporated	Process for reducing RNA concentration in a mixture of biological material using diatomaceous earth
EP0880536B2 (fr)	1996-02-06	2015-08-05	Roche Diagnostics GmbH	Procede pour la preparation d'acide nucleique purifie et utilisation de ce dernier

1996
- 1996-03-21 FR FR9603519A patent/FR2746412B1/fr not_active Expired - Fee Related
1997
- 1997-03-17 IL IL12626897A patent/IL126268A0/xx unknown
- 1997-03-17 BR BR9708227A patent/BR9708227A/pt not_active Application Discontinuation
- 1997-03-17 HU HU9902152A patent/HU225426B1/hu not_active IP Right Cessation
- 1997-03-17 KR KR10-1998-0707410A patent/KR100502116B1/ko not_active IP Right Cessation
- 1997-03-17 SK SK1291-98A patent/SK129198A3/sk unknown
- 1997-03-17 CA CA002249465A patent/CA2249465A1/fr not_active Abandoned
- 1997-03-17 WO PCT/FR1997/000472 patent/WO1997035002A1/fr not_active Application Discontinuation
- 1997-03-17 JP JP9533199A patent/JP2000506736A/ja active Pending
- 1997-03-17 CZ CZ19982984A patent/CZ295587B6/cs not_active IP Right Cessation
- 1997-03-17 EP EP97914411A patent/EP0902835A1/fr not_active Ceased
- 1997-03-17 AU AU21661/97A patent/AU730755B2/en not_active Ceased
- 1997-03-20 ZA ZA9702462A patent/ZA972462B/xx unknown
1998
- 1998-09-15 US US09/153,838 patent/US6730781B1/en not_active Expired - Fee Related
- 1998-09-18 NO NO984342A patent/NO984342D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR9708227A (pt)	1999-07-27
HUP9902152A2 (hu)	1999-11-29
NO984342L (no)	1998-09-18
CZ298498A3 (cs)	1999-01-13
ZA972462B (en)	1997-09-29
AU730755B2 (en)	2001-03-15
FR2746412A1 (fr)	1997-09-26
FR2746412B1 (fr)	1998-06-12
WO1997035002A1 (fr)	1997-09-25
EP0902835A1 (fr)	1999-03-24
IL126268A0 (en)	1999-05-09
CZ295587B6 (cs)	2005-08-17
KR20000064693A (ko)	2000-11-06
CA2249465A1 (fr)	1997-09-25
KR100502116B1 (ko)	2005-12-20
HUP9902152A3 (en)	2001-04-28
JP2000506736A (ja)	2000-06-06
HU225426B1 (en)	2006-11-28
US6730781B1 (en)	2004-05-04
NO984342D0 (no)	1998-09-18
AU2166197A (en)	1997-10-10

Publication	Publication Date	Title
SK129198A3 (en)	1999-03-12	Purification of pharmaceutical-grade plasmid dna
JP2009045070A (ja)	2009-03-05	固定化させたオリゴヌクレオチドと三重らせんを形成させることによるｄｎａ精製
US8399636B2 (en)	2013-03-19	Purification of a triple helix formation with an immobilized obligonucleotide
AU2007202804B2 (en)	2011-04-07	Purification of a triple helix formation with an immobilized oligonucleotide
MXPA98007323A (en)	1999-04-06	Purification of plasmid dna of pharmaceutical quality
AU2001263459A1 (en)	2002-02-28	Purification of a triple heli formation with an immobilized oligonucleotide
IL152860A (en)	2010-11-30	Purification of dna by a triple helix formation with an immobilized oligonucleotide
PL206844B1 (pl)	2010-09-30	Sposoby oczyszczania dwuniciowego DNA